Joachim Eeckhout, Author at Labiotech.eu

About

Founder & Managing Director at Labiotech.eu. While I was studying biotechnology in Paris, I got frustrated by the lack of digital media available for the industry and decided to fix it! I launched Labiotech.eu in 2014 and grew it to the largest community for biotech professionals in Europe! Other than biotech news, I’m also a heavy reader of Sci-Fi and Fantasy.

Articles by Joachim Eeckhout

News and Trends 3 Jul 2015

Yes! Humanity can finally produce Oxygen!

Julian Melchiorri, a student of the Royal College of Art of London is making quite of a buzz outside of Scientists frontiers with his Silk Leaf. A revolutionary material capable of producing O2 from CO2 designed on biomimicry principle. Info or Intox? We’ll let you make your own mind up on the question! For a few years now, […]

July 3, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 2 Jul 2015

Biotech & Medtech well represented at Europe’s largest technological start-up challenge

The second edition of the Hello Tomorrow Conference, a major event dedicated to disruptive technologies and science entrepreneurship, took place last week in Paris. This event gathered scientists, entrepreneurs and investors during two days to share & present the scientific innovations that will shape our future. It gathered 6 different scientific fields structures, including Healthcare and […]

July 2, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 1 Jul 2015

mRNA Therapies: CureVac Outperformed the Money Magnet Moderna

Everybody has already heard about Boston-based Moderna Therapeutics, the most highly valued venture-backed private Biotech, but CureVac, its German competitor, remains much more understated. This could rapidly change as CureVac just demonstrated that its technology beats Moderna’s. mRNA technologies could theoretically disrupt the whole drug industry. Imagine that you can directly inject mRNA into patients to make them produce their own therapeutic proteins. Unfortunately, […]

July 1, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 30 Jun 2015

Stallergenes and Greer to create the World Leader in Allergy Immunotherapy

A few months ago, we were talking about the refusal of Stallergenes’ minority shareholders to merge with Greer laboratories, another competitor within the field of allergy treatment. Finally, Stallergenes shareholders accepted, and both companies are going to create the world leader in allergy immunotherapy. After the sale of Serono to Merck back in 2007, the magnate Ernesto Bertarelli started its […]

June 30, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 30 Jun 2015

Oldest French Biotech Transgene is One Step Closer to Bankruptcy

Transgene, the oldest French Biotech company announced just yesterday that it will cut 120 jobs on its current 300 employees. The company will shut down its manufacturing facility in order to focus on the Research and Development of its therapeutic vaccine candidates. Wise move or final last words? Back in 1976, Robert Swanson and Herbert Boyer founded […]

June 30, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 29 Jun 2015

Novartis pays €625M for Spinifex’s chronic pain treatment

[Update 06.30.2015] According to an email sent to FierceBiotech by Spinifex’s CEO Tom McCarthy, Novartis could pay an additional $500m (approximately €445m) of future milestones to Spinifex’s shareholders. Spinifex Pharmaceuticals, a US-Australian biotechnology company has just been bought by Novartis. With this acquisition, the Swiss giant aims to control the development of EMA401, a new treatment for […]

June 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 25 Jun 2015

Video: Discover How CAR-T Therapies are Working

It’s becoming a habit for us to talk about CAR-T therapies. It’s basically the next wave of treatments against cancer and already promises to be the future blockbusters and growth drivers of the whole Biotech industry. Cellectis, a leading company in this field, just published a cool video about CAR-Ts. Of course, they’re describing more specifically their own therapy, […]

June 25, 2015 - 1 minutemin - By Joachim Eeckhout

News and Trends 22 Jun 2015

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Each year, BIO Philadelphia awards the Everyday Superheroes of Biotech Industry. Here’s the story of Bernard Muller, co-founder of Treeway, a Dutch biotech company focused on the treatment of Amyotrophic lateral sclerosis (ALS). Bernard Muller is an extraordinary person, being himself a ALS patient and an entrepreneur who started his own Biotech company. Last week, we were talking […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 22 Jun 2015

American Companies are Invading London’s Biotech Stock Market

[Update: On June 19, Puretech successfully raised $171M – approximately €150M – during its IPO, setting its market cap at €509M] Boston-based PureTech Health plans to raise €147M on the London stock market, following the path of Verseon, a San Diego-based bioinformatic company that raised €92M earlier this month. Is there a new American trend to earn cash in […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Jun 2015

Biotech to Revolutionize the Millennial Production of Carmine!

The Danish company Chr Hansen, through a partnership with the University of Copenhagen, created a process able to produce carmine dye by fermentation. Thanks to this discovery, the company is disrupting a millennial production method and stepping up to the plate, becoming a real game changer. With its particular deep-red color, carmine is one of the most […]

June 21, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 17 Jun 2015

Deinove to challenge the Carotenoid Business

Carotenoids are powerfull antioxidants and essential in the production of vitamin A. The French synthetic biology biotech Deinove signed an agreement with the Canadian company POS Bio-Sciences with the hope of initiating a major breakthrough to the carotenoid market. Produced by all green plants, algae, some fungi and cyanobacteria, carotenoid is a group of more than 600 known […]

June 17, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 16 Jun 2015

Novartis Uses Antibodies from Cured Patients to Fight Viruses

Novartis just paid the bill to Humabs to use its out-licensed drug candidate in a Phase II clinical trial. This monoclonal antibody was developed thanks to Humabs’ technology platform using antibodies from cured patients. Back in 2009, Humabs and Novartis entered into an exclusive licensing agreement for the use of selective human monoclonal antibodies discovered by […]

June 16, 2015 - 2 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Joachim Eeckhout

About

Articles by Joachim Eeckhout

Yes! Humanity can finally produce Oxygen!

Biotech & Medtech well represented at Europe’s largest technological start-up challenge

mRNA Therapies: CureVac Outperformed the Money Magnet Moderna

Stallergenes and Greer to create the World Leader in Allergy Immunotherapy

Oldest French Biotech Transgene is One Step Closer to Bankruptcy

Novartis pays €625M for Spinifex’s chronic pain treatment

Video: Discover How CAR-T Therapies are Working

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

American Companies are Invading London’s Biotech Stock Market

Biotech to Revolutionize the Millennial Production of Carmine!

Deinove to challenge the Carotenoid Business

Novartis Uses Antibodies from Cured Patients to Fight Viruses

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Joachim Eeckhout

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!